Michael Saad

Michael Saad practices at Atrium Health University City in Charlotte, North Carolina, part of Advocate Health.

Michael Saad's NPI, 1366600991, was assigned on May 30, 2008. Michael Saad holds North Carolina license 2012-01032.

Michael Saad's primary practice is Atrium Health University City, at 8800 North Tyron Street, Charlotte, NC 28262 in Mecklenburg County. The practice phone is (704) 548-6000.

Michael Saad's primary practice is Atrium Health University City in Charlotte, North Carolina, part of Advocate Health. The medical group on file is Wake Forest Emergency Providers. Dmand AI also links Michael Saad to 2 more group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Saad practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Michael Saad's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Michael Saad is licensed in North Carolina.

CMS data shows 167 Medicare services from Michael Saad across 4 procedure codes in 2024, for 129 Medicare patients. Medicare paid $10,918 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Michael Saad in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Saad's median patient age at 63, with 56% women.

In 2024, Michael Saad wrote 153 Medicare Part D claims for 79 patients. 93% of them were for generic drugs. CMS names the drug for 59 of them, across 4 drugs with 11 or more claims each, at $303 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Michael Saad for performance year 2024, reported through an alternative payment model (APM). Michael Saad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Michael Saad, published from 2021 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Adipocytes, Adipose Tissue and Cell Line. Michael Saad has published most often in Biomaterials. Michael Saad's most frequent co-authors are Fereshteh Azad, MD, Mark S. Juzych, MD and Hassan Ali Tokko, MD.

CMS Open Payments shows 2 general payments to Michael Saad from 2 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Gebauer Company paid the most, $62.